Apellis Pharmaceuticals, Inc (APLS): SCHEDULE 13G/A filed Jun 5, 2026

Form type

SCHEDULE 13G/A

Filing date

Jun 5, 2026

Accession number

0000895421-26-000190

Filer

Apellis Pharmaceuticals, Inc (CIK 1492422)